Akinsanya Karen, President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships exercised 31,599 shares of Schrodinger, Inc. ($SDGR) @ $4.34 ($137,139.66 total) on Sep 17, 2026

Akinsanya Karen – President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships

Sep 17, 2026

52W Low$10.95

Current$30.2496.1% above low, 3.9% below high

Purchase$4.34-32.9% above low, 132.9% below high

52W High$31.03

31,599

Price

$4.34

Total Value

$137,139.66

Nearby Earnings

No earnings within 2 weeks of this transaction.

Insider	Akinsanya Karen
Title	President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Transaction Date	Sep 17, 2026
Transaction Code	M Exercise/Conversion
Acquired/Disposed	Acquired
Security	Common Stock
Direct/Indirect	Direct
Filing Date	Sep 21, 2026
Shares Purchased	31,599
Price per Share	$4.34
Total Value	$137,139.66
Shares Owned After	101,555
Derivative	No
Accession Number	0001797672-26-000006
Document	View SEC Filing